메뉴 건너뛰기




Volumn 30, Issue 1, 2002, Pages 147-156

The Trp53 hemizygous mouse in pharmaceutical development: Points to consider for pathologists

Author keywords

Alternative model; Bioassay; Cancer; Carcinogenicity; Genetically modified; Knockout; p53; Short term assay; Tumor

Indexed keywords

4 CRESIDENE; BENZENE; CARCINOGEN; DNA; GENE PRODUCT; PARA CRESOL; PROTEIN P53; UNCLASSIFIED DRUG;

EID: 0036185657     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230252824860     Document Type: Article
Times cited : (11)

References (36)
  • 15
    • 0032559530 scopus 로고    scopus 로고
    • Guidance on testing for carcinogenicity of pharmaceuticals
    • (1998) Fed Reg , vol.63 , pp. 8983-8986
  • 21
    • 0030941458 scopus 로고    scopus 로고
    • p53, the cellular gatekeeper for growth and division
    • (1997) Cell , vol.88 , pp. 323-331
    • Levine, A.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.